2-methyspiro(1,3-oxathiolane-5,3)quinuclidine,
AF 102B,
AF 102B, (cis-(+))-isomer,
AF 102B, (trans)-isomer,
AF-102B,
AF102B,
cevimeline,
cevimeline hydrochloride,
Evoxac,
FKS 508,
FKS-508,
SNI 2011,
SNI-2011,
Cevimeline,
107233-08-9,
Cevimeline [INN],
Cevimeline hydrochloride,
Evoxac,
C10H17NOS,
Fks 508,
Cevimeline (INN),
Saligren,
Cevimeline HCl,
AF-102B,
HSDB 7286,
2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine,
AF102B,
AF 102B,
FKS-508,
SNI-2011,
cevimeline hydrochloride hydrate,
PubChem19118,
cevimeline trans-sulfoxide,
AC1L36EF,
BIDD:GT0265,
SCHEMBL188381,
CHEMBL1201267,
DTXSID2023777,
CTK8E6849,
ZINC10163,
Spiro(1-azabicyclo(2.2.2)octane-3,5'-(1,3)-oxathiolane), 2'-methyl-, (2'R,3R)-rel-,
Spiro(1-azabicyclo(2.2.2)octane-3,5'-(1,3)-oxathiolane), 2'-methyl-, cis-,
KS-00000XL8,
AKOS025294043,
CS-0397,
AN-33787,
HY-70020,
LS-172037,
RT-011982,
FT-0771641,
X7254,
D07667,
W-5959,
UNII-K9V0CDQ56E component WUTYZMFRCNBCHQ-PSASIEDQSA-N,
(2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane],
(3R,2'R)-2'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-[1,3]oxathiolane],
Cevimeline N-Oxide,
Cevimeline Sulfoxide,
Sni 2011,
UNII-K9V0CDQ56E,
Cevimeline Hydrochloride Salt,
AF 102B, (trans)-isomer,
C10-H17-N-O-S,
Cevimeline hydrochloride hemihydrate,
AF 102B, (cis-(+))-isomer,
CID83898,
CB11424,
2569B,
A3299,
C059240,
(+-)-cis-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine],
(+/-)-cis-2-Methylspiro[1,3-oxathiolane-5,3'-quinuclidine],
124751-36-6,